Mohamad Merhi was Promoted as Vice President of Product Delivery at MD-Group

Date of management change: June 16, 2022 

What Happened?

Durham, NC-based MD-Group Promoted Mohamad Merhi as Vice President of Product Delivery

 

About the Company

We`re on a mission to make life better for patients taking part in clinical trials around the world, and their caregivers. Our solutions focus on the four key elements of a successful clinical trial: recruitment, engagement, retention and trial outcomes. Combining our in-house technology platforms with 24/7 truly personalised patient care, we focus on creating remarkable patient experiences at every stage of the clinical journey. Remarkable means going above and beyond to support patients in a way that works best for them and their lives. Whether that`s facilitating clinical trial participation in their own homes, supporting them to travel safely to and from study sites, or using technology to manage everything from expense reimbursement to telehealth, we work with our partners to support the protocol design that meets their patient`s needs. Understanding the complexities of the patient journey is paramount to advancing medicine, and exploring digital technology that enables better trial outcomes has never been more important. This all starts with putting patients first in clinical research. When you partner with us, your patients receive a truly remarkable service and your trial outcomes are better.

 

About the Person

Mohamad Merhi is Vice President of Product Delivery at MD Group. Previously, Mohamad held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Davis Teresa, Lewis-Stoner Melissa, Dicicco Jessica, Jardine Ralph, Ebersole Mark, Lanford James, Schmid Gerrard, Walker Diane, Lazzaro Cheryl, Connor Ann, Nicol Jim

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.